help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bradshaw, S. L.
Right arrow Articles by Han, V. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bradshaw, S. L.
Right arrow Articles by Han, V. K.

Endocrinology, Vol 133, 1767-1777, Copyright © 1993 by Endocrine Society


ARTICLES

Hormonal regulation of astroglial insulin-like growth factor (IGF)- binding protein gene expression by IGFs and insulin

SL Bradshaw and VK Han
Medical Research Council Group in Fetal and Neonatal Health and Development, University of Western Ontario, London, Canada.

Primary astroglial cells produce insulin-like growth factor (IGF)- binding proteins (IGFBPs), which modulate the biological activity of IGFs on the developing astroglia. Alterations in the synthesis of astroglial IGFBPs by hormones and growth factors may, therefore, influence the paracrine regulatory actions of IGFs. The objective of this study was to examine the regulation of astroglial IGFBP biosynthesis by IGF-I, IGF-II, and insulin. Primary astroglial cells were cultured from newborn rat cerebral cortices. Conditioned media from astroglial cultures without (control) or with hormonal treatment (10, 100, and 200 ng/ml IGF-I or IGF-II and 0.1, 1.0, and 10 micrograms/ml insulin) were collected and subjected to Western ligand blot analysis. Total RNAs were extracted from the same cultures and subjected to Northern blot analysis. Two IGFBP species of 34K (IGFBP-2) and 40K (IGFBP-3) were identified. After 24 h of treatment, IGF-I, IGF- II, and high concentrations of insulin increased IGFBP-2 and IGFBP-3 levels. At 24 h, IGFBP-2 stable mRNA levels showed an increase corresponding to the protein levels; however, IGFBP-3 stable mRNA levels did not. Time-course studies demonstrated that IGF-I rapidly induced the mRNA levels of both IGFBP-2 and IGFBP-3 within 7.5-12 h. IGFBP-2 mRNA levels showed a biphasic response to IGF-I, a rapid increase at 7.5 h, followed by a decline at 12-18 h, and then another increase at 24 h. In contrast, IGFBP-3 mRNA levels showed a response that peaked at 7.5-12 h and decreased to control levels at 24 h. The stability of IGFBP-2 mRNA at 24 h of IGF-I treatment was not significantly altered from that under control conditions, indicating that the changes in IGFBP-2 mRNA levels were not due to alterations in the stability of the mRNA. In situ hybridization studies demonstrated an increase in the abundance per cell of IGFBP-2 and IGFBP-3 mRNAs in either one or both types of astroglial cells after IGF-I or IGF-II treatment. We conclude that, 1) IGFs differentially modulate the production of astroglial IGFBPs; 2) the increase in IGFBP mRNA levels by IGFs is rapid and biphasic; 3) the effects of IGFs on IGFBP stable mRNAs may occur at the level of gene transcriptions; and 4) the effect of IGFs on IGFBP gene expression may be cell type specific.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
EndocrinologyHome page
S. L. Bradshaw, A. J. D’Ercole, and V. K. M. Han
Overexpression of Insulin-Like Growth Factor-Binding Protein-2 in C6 Glioma Cells Results in Conditional Alteration of Cellular Growth
Endocrinology, February 1, 1999; 140(2): 575 - 584.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. J. Horney, D. W. Shirley, D. T. Kurtz, and S. A. Rosenzweig
Elevated glucose increases mesangial cell sensitivity to insulin-like growth factor I
Am J Physiol Renal Physiol, June 1, 1998; 274(6): F1045 - F1053.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society